4D Molecular Therapeutics Overview4D Molecular Therapeutics Other Income Expense Net
Other Income/Expense Net for FDMT.
Quarterly Other Income/Expense
$4.86M
↓ 13.97% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$18.65M
↓ 30.64% YoY
Trailing 12 months ending Mar 31, 2026